Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human ATAD2 Protein, N-His

Catalog #:   YHJ07601 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: Q6PL18
Protein length: Ser245-Glu396
Overview

Catalog No.

YHJ07601

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

Ser245-Glu396

Predicted molecular weight

20.42 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

Q6PL18

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

AAA nuclear coregulator cancer-associated protein, ANCCA, ATAD2, ATPase family AAA domain-containing protein 2

Data Image
  • SDS-PAGE
    SDS PAGE for recombinant Human ATAD2 protein
References

BRD9 functions as an HIV-1 latency regulatory factor., PMID:40402245

ATAD2 bromodomain in cancer therapy: current status and future perspectives., PMID:40334884

Competitive binding between DDX21 and SIRT7 enhances NAT10-mediated ac4C modification to promote colorectal cancer metastasis and angiogenesis- DDX21 promotes colorectal cancer metastasis., PMID:40301349

ATAD2 Drives Prostate Cancer Progression to Metastasis., PMID:39907729

ATAD2 is a potential immunotherapy target for patients with small cell lung cancer harboring HLA-A∗0201., PMID:39808946

Targeting WDR5/ATAD2 signaling by the CK2/IKAROS axis demonstrates therapeutic efficacy in T-ALL., PMID:39785511

ATAD2 and TWIST1 Interaction Promotes MYC Activation in Colorectal Carcinoma., PMID:39686835

FOXM1 Transcriptionally Co-Upregulates Centrosome Amplification and Clustering Genes and Is a Biomarker for Poor Prognosis in Androgen Receptor-Low Triple-Negative Breast Cancer., PMID:39335162

Pan-cancer analysis of the immunological and oncogenic roles of ATAD2 with verification in papillary thyroid carcinoma., PMID:39333272

Role and Regulatory Mechanism of circRNA_14820 in the Proliferation and Differentiation of Goat Skeletal Muscle Satellite Cells., PMID:39201586

Assessment of Recovery Time Effects on Human Primary Neonatal Dermal Fibroblasts After Exposure to Solar-Simulated Ultraviolet Radiation., PMID:39050996

Elevated expression of ECT2 as a diagnostic marker and prognostic indicator in endometrial cancer., PMID:38977110

Impact of Combinatorial Histone Modifications on Acetyllysine Recognition by the ATAD2 and ATAD2B Bromodomains., PMID:38733345

Hypoxia-Inducible Factor-Dependent and Independent Mechanisms Underlying Chemoresistance of Hypoxic Cancer Cells., PMID:38730681

PharmaCore: The Automatic Generation of 3D Structure-Based Pharmacophore Models from Protein/Ligand Complexes., PMID:38728062

Methionine secreted by tumor-associated pericytes supports cancer stem cells in clear cell renal carcinoma., PMID:38378000

Proteomic profiling of urinary extracellular vesicles differentiates breast cancer patients from healthy women., PMID:37922300

Structure of the human ATAD2 AAA+ histone chaperone reveals mechanism of regulation and inter-subunit communication., PMID:37770645

MicroRNA-139-5p suppresses non-small cell lung cancer progression by targeting ATAD2., PMID:37595446

Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells., PMID:37533352

ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPE., PMID:37479754

Predicted Configuration and Stability of the ATAD2/SOX10 Complex Using Molecular Dynamics Simulations., PMID:37168970

Identification of POLQ as a key gene in cervical cancer progression using integrated bioinformatics analysis and experimental validation., PMID:37114556

Cell-Free RNA from Plasma in Patients with Neuroblastoma: Exploring the Technical and Clinical Potential., PMID:37046768

Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review., PMID:36674511

ATPase family AAA domain-containing protein 2 (ATAD2): From an epigenetic modulator to cancer therapeutic target., PMID:36632213

Multi-layered chromatin proteomics identifies cell vulnerabilities in DNA repair., PMID:36629267

ATAD2 Upregulation Promotes Tumor Growth and Angiogenesis in Endometrial Cancer and Is Associated with Its Immune Infiltration., PMID:36479043

Genome-wide survey of D/E repeats in human proteins uncovers their instability and aids in identifying their role in the chromatin regulator ATAD2., PMID:36404917

Mapping Ligand Interactions of Bromodomains BRD4 and ATAD2 with FragLites and PepLites─Halogenated Probes of Druglike and Peptide-like Molecular Interactions., PMID:36367089

Exiting the tunnel of uncertainty: crystal soak to validated hit., PMID:36322414

ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells., PMID:36279679

A targetable MYBL2-ATAD2 axis governs cell proliferation in ovarian cancer., PMID:36151333

miR-302 Suppresses the Proliferation, Migration, and Invasion of Breast Cancer Cells by Downregulating ATAD2., PMID:36139505

Exosomal microRNA-506 inhibits biological activity of lung adenocarcinoma cells and increases sensitivity to cisplatin-based hyperthermia., PMID:36115547

Aspirin Exerts Its Antitumor Effect in Esophageal Squamous Cell Carcinoma by Downregulating the Expression of ATAD2 and KIF4A., PMID:36046597

Identification of novel key genes and potential candidate small molecule drugs in diabetic kidney disease using comprehensive bioinformatics analysis., PMID:36035169

Tumor-Promoting ATAD2 and Its Preclinical Challenges., PMID:36008934

Integrated Analysis of mRNAs and Long Non-Coding RNAs Expression of Oviduct That Provides Novel Insights into the Prolificacy Mechanism of Goat (Capra hircus)., PMID:35741792

YAP1 maintains active chromatin state in head and neck squamous cell carcinomas that promotes tumorigenesis through cooperation with BRD4., PMID:35705032

Effect of chronic intermittent hypoxia-induced HIF-1α/ATAD2 expression on lung cancer stemness., PMID:35672694

MicroRNA-217 modulates pancreatic cancer progression via targeting ATAD2., PMID:35504332

Discovery of a Potent and Selective ATAD2 Bromodomain Inhibitor with Antiproliferative Activity in Breast Cancer Models., PMID:35133824

ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors., PMID:35085891

The association between bromodomain proteins and cancer stemness in different solid tumor types., PMID:35049055

Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase., PMID:34973392

Evaluation of ATAD2 as a Potential Target in Hepatocellular Carcinoma., PMID:34738187

ATAD2 controls chromatin-bound HIRA turnover., PMID:34580178

Developmental chromatin programs determine oncogenic competence in melanoma., PMID:34516843

Coordination of Di-Acetylated Histone Ligands by the ATAD2 Bromodomain., PMID:34502039

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human ATAD2 Protein, N-His [YHJ07601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only